Does a Specimen-Based Margin Analysis of Early Tongue Cancer Better Predict Local Control?
Mark A. Varvares, MD; Ronald J Walker, MD; Simion Chiosea, MD BACKGROUND Oral cavity cancer continues to be a significant disease in the United States despite decreasing smoking rates. Surgery remains the primary treatment modality for operable oral cavity cancer, with adjuvant therapy reserved for patients with high-risk histologic characteristics. The ability to achieve primary-site disease control is directly related to the completeness of the surgical resection. Maintaining a disease-free primary site and preventing local recurrence is key to improving overall survival, particularly in patients with early cancer without nodal disease.
A survey of head and neck surgeons indicated that the majority determines surgical margins by obtaining intraoperative frozen sections from the tumor bed. 1 A survey of pathologists likewise indicated that most received small pieces of tissue from the surgeon for frozen section analysis. 2 Three recent studies that address this issue in oral cancer resections, one retrospective, and two prospective, with all including cohorts of both specimen and tumor bed based analysis suggest that margin sampling from the main resection specimen, a specimen-driven approach, may more accurately determine the adequacy of resection and better predict local control.
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LITERATURE REVIEW
Maxwell et al. 3 performed a multicenter retrospective analysis of patients with pT1-2N0 oral tongue squamous cell carcinoma. They reviewed 280 patients with pT1-T2N0 squamous cell carcinoma of the oral tongue that were divided into three surgical workflow groups (Fig. 1) . Group 1 had margins assessed from the glossectomy specimen only with no tumor bed sampling (n 5 119). Group 2 (i.e., revision group) had intraoperative evaluation of the glossectomy specimen by a pathologist. If the resection was felt to be positive or otherwise suboptimal (distorted, ulcerated, or lacking mucosa at the mucosal margin) the surgeon revised the margins by obtaining additional margins from the tumor bed (n 5 61). In group 3, all margins were sampled primarily from the tumor bed without intraoperative evaluation of the glossectomy specimen (n 5 100). They found that the frequency of positive glossectomy margins was lowest in group 1 at 7.7%, compared to group 2 (45.9%) and group 3 (24.2%). After excluding patients with positive margins, the distance from the invasive tumor front to the closest margin was significantly narrower in group 3 at 1 mm as opposed to group 1 at 3 mm. The difference in local recurrence-free survival at 3 years between groups 1 and 2 was not significantly different (0.9 vs. 0.8; P 5 .06). However, the 3-year local recurrence-free survival was worse for group 3 compared to that in group 1 (0.8 vs. 0.9, respectively; P 5 .03). It was noted that in group 3, whereas 24% had positive glossectomy margins when evaluating the main specimen, only 7.4% had positive tumor bed margins. If margins obtained from the glossectomy specimen are considered the standard, sampling the tumor bed margin was only 24% sensitive (95% confidence interval [CI]: 16%-34%) and 92% specific (95% CI: 85%-97%) for detecting a positive margin. Local recurrence-free survival at 3 years differed significantly between patients with positive glossectomy specimen margins and those with negative glossectomy specimen margins (0.73 vs. 0.86, respectively; P 5 .007). Only glossectomy margin status significantly correlated with local recurrence-free survival. The status of tumor bed margins was of no prognostic value with regard to local recurrence-free survival.
The issue of improved margin assessment from the specimen versus the tumor bed has been addressed in two pilot prospective trials. Yahalom et al. 4 prospectively studied the outcomes of three groups of patients who were treated for oral cavity cancer and who underwent different methodologies of margin analysis. In the first group, frozen sections were taken at random locations and numbers from the tumor bed. In the second group, frozen sections were taken according from a strict protocol, but from the surgical bed. In the third group, frozen sections were taken in accordance with an outlined protocol, but from the main tumor specimen. If frozen sections were found to be positive, the margins were revised. The incidence of final positive margins as determined by analysis of the glossectomy specimen on final sampling was 40%, 40%, and 17%, respectively, for groups 1, 2, and 3. Overall survival for group 1 was 66% with clear margins and 50% with positive margins. In group 2, overall survival was 80% with clear margins and 66% if positive. In group 3, the overall survival was 100% for clear and initially positive margins that were converted to clear. The study concluded that sampling from the resected tumor specimen had the best correlation with final margin status and disease control.
Amit and coworkers 5 recently reported the results of a prospective, randomized, blinded controlled trial evaluating the difference in efficacy between the two approaches-specimen versus patient-based margin analysis-in achieving negative margins in oral cavity cancer resections in a group of patients without prior treatment. Two cohorts were studied; a specimen-driven assessment of margins in which the margins are measured from the excised specimen using frozen section evaluation and the patient-driven assessment in which margins are sampled from the patient side after tumor resection using frozen section. The final endpoint was the rate of negative margins in the final pathological assessment of the formalin-fixed paraffin-embedded tissue. Five millimeters was used as the definition of a negative margin, and less than 5 mm was considered positive/close. Patients were randomized using a computer-generated list equilibrated to every eight patients. At a second interim analysis, which included 20 patients in the patient-driven arm and 17 in the specimen-driven arm, a significantly higher rate of positive margins was found in the patient-driven arm; enrollment into this arm was stopped with all of the remaining patients enrolled into the specimen-driven arm. A total of 71 patients were analyzed, 29 in the patient-driven arm and 51 in the specimen-driven arm. Overall, positive or close margins were noted in 45% of the patients in the patient-driven arm as opposed to 16% in the specimen-driven arm. The overall sensitivity of the specimen-driven margin technique in predicting final clear margins was 91% compared to 22% for the patient-driven margin technique. They concluded that the lack of consensus on the best methodology of margin analysis may bring potential impediments on selecting adjuvant treatment when based on status of the surgical margins.
BEST PRACTICE
Achieving complete tumor resection and improved local control is a major driver in predicting diseasespecific survival in patients with early tongue cancer without nodal disease. There is a growing level of evidence that in the treatment of early oral cavity cancer, margin sampling from the primary resection specimen better reflects the adequacy of excision and predicts local control when compared to tumor bed sampling. Patients with T1 and T2N0 oral tongue cancer are likely to benefit a from specimen-driven margin assessment.
LEVEL OF EVIDENCE
This review cites one level 1a study, one 2b study, and one level 3b study. 
